Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial

Woo Hyun Paik, Joo Kyung Park, Moon Jae Chung, Gunn Huh, Ce Hwan Park, Sang Hyub Lee, Heon Se Jeong, Hee Jin Kim, Do Hyun Park

Clin Mol Hepatol. 2025;31(1):119-130. Published online September 24, 2024

DOI: https://doi.org/10.3350/cmh.2024.0629

View: 871 Download: 173

Case Report

Acute pancreatitis associated with pegylated interferon-alpha-2a therapy in chronic hepatitis C

Jong Wook Choi, June Sung Lee, Woo Hyun Paik, Tae Jun Song, Jung Wook Kim, Won Ki Bae, Kyung-Ah Kim, Jung Gon Kim

Clin Mol Hepatol. 2016;22(1):168-171. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.168

View: 10255 Download: 82 Web of Science: 5 Crossref: 7

Original Article

Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients

Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa

Clin Mol Hepatol. 2015;21(1):41-48. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.41

View: 9084 Download: 85 Web of Science: 15 Crossref: 11

Correspondence

Correspondence to editorials on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”

Woo Hyun Paik, Do Hyun Park

Received November 4, 2024 Accepted November 7, 2024

DOI: https://doi.org/10.3350/cmh.2024.0989 [Accepted]

View: 273 Download: 16

1 |

Viewed By 6265	MAFLD: How is it different from NAFLD?
Viewed By 5317	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5042	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4180	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 3960	Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Cited By 272	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 225	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 155	MAFLD: How is it different from NAFLD?
Cited By 79	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 76	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search